Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

Aug 18, 2025 - 17:00
 0  0
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0